GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $300,000 | -2.0% | 6,893 | -1.8% | 0.06% | +12.0% |
| Q1 2022 | $306,000 | +3.7% | 7,018 | -0.4% | 0.05% | +2.0% |
| Q4 2021 | $295,000 | -3.6% | 7,048 | -12.0% | 0.05% | -5.8% |
| Q3 2021 | $306,000 | -25.7% | 8,010 | -22.5% | 0.05% | -27.8% |
| Q2 2021 | $412,000 | +7.0% | 10,340 | -4.1% | 0.07% | -1.4% |
| Q1 2021 | $385,000 | -74.4% | 10,780 | -73.6% | 0.07% | -76.8% |
| Q4 2020 | $1,502,000 | -33.1% | 40,822 | -31.5% | 0.31% | -38.6% |
| Q3 2020 | $2,244,000 | -6.7% | 59,632 | +1.2% | 0.51% | -14.4% |
| Q2 2020 | $2,404,000 | +7.6% | 58,933 | -0.1% | 0.60% | -11.6% |
| Q1 2020 | $2,235,000 | -19.3% | 58,998 | +0.1% | 0.68% | +2.7% |
| Q4 2019 | $2,770,000 | +14.3% | 58,948 | +3.8% | 0.66% | +4.8% |
| Q3 2019 | $2,423,000 | +5.9% | 56,783 | -0.6% | 0.63% | +1.1% |
| Q2 2019 | $2,287,000 | -0.3% | 57,138 | +4.1% | 0.62% | -4.2% |
| Q1 2019 | $2,293,000 | +19.7% | 54,879 | +9.5% | 0.65% | +3.5% |
| Q4 2018 | $1,915,000 | +0.1% | 50,137 | +5.3% | 0.62% | +13.8% |
| Q3 2018 | $1,913,000 | -0.9% | 47,631 | -0.6% | 0.55% | -7.7% |
| Q2 2018 | $1,931,000 | +2.4% | 47,899 | -0.8% | 0.60% | -1.2% |
| Q1 2018 | $1,886,000 | +14.1% | 48,277 | +3.6% | 0.60% | +15.1% |
| Q4 2017 | $1,653,000 | -12.4% | 46,619 | +0.2% | 0.52% | -17.2% |
| Q3 2017 | $1,888,000 | -3.4% | 46,507 | +2.6% | 0.63% | -8.3% |
| Q2 2017 | $1,955,000 | +15.3% | 45,342 | +12.7% | 0.69% | +8.5% |
| Q1 2017 | $1,696,000 | +13.6% | 40,248 | +3.8% | 0.64% | +9.5% |
| Q4 2016 | $1,493,000 | +2.5% | 38,775 | +14.8% | 0.58% | -7.9% |
| Q3 2016 | $1,457,000 | -2.0% | 33,775 | -1.5% | 0.63% | -4.8% |
| Q2 2016 | $1,486,000 | +16.2% | 34,295 | +8.7% | 0.66% | +3.4% |
| Q1 2016 | $1,279,000 | -0.5% | 31,547 | -0.9% | 0.64% | -3.3% |
| Q4 2015 | $1,285,000 | +1.3% | 31,847 | -3.4% | 0.66% | -4.3% |
| Q3 2015 | $1,268,000 | -7.6% | 32,983 | +0.1% | 0.69% | -1.0% |
| Q2 2015 | $1,373,000 | -4.6% | 32,958 | +5.7% | 0.70% | -4.8% |
| Q1 2015 | $1,439,000 | +16.1% | 31,183 | +7.6% | 0.73% | +12.9% |
| Q4 2014 | $1,239,000 | +5.2% | 28,991 | +13.2% | 0.65% | -0.6% |
| Q3 2014 | $1,178,000 | -0.7% | 25,619 | +4.4% | 0.65% | -4.2% |
| Q2 2014 | $1,186,000 | -10.1% | 24,532 | -0.7% | 0.68% | -15.0% |
| Q1 2014 | $1,319,000 | +2.8% | 24,694 | +2.7% | 0.80% | -0.4% |
| Q4 2013 | $1,283,000 | – | 24,044 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |